The treatment of axonal disorders, such as diseases associated with axonal injury and degeneration, is limited by the inability to directly target therapeutic protein expression to injured axons. Current gene therapy approaches rely on infection and transcription of viral genes in the cell body. Here, we describe an approach to target gene expression selectively to axons. Using a genetically engineered mouse containing epitope-labeled ribosomes, we find that neurons in adult animals contain ribosomes in distal axons. To use axonal ribosomes to alter local protein expression, we utilized a Sindbis virus containing an RNA genome that has been modified so that it can be directly used as a template for translation. Selective application of this virus to axons leads to local translation of heterologous proteins. Furthermore, we demonstrate that selective axonal protein expression can be used to modify axonal signaling in cultured neurons, enabling axons to grow over inhibitory substrates typically encountered following axonal injury. We also show that this viral approach also can be used to achieve heterologous expression in axons of living animals, indicating that this approach can be used to alter the axonal proteome in vivo. Together, these data identify a novel strategy to manipulate protein expression in axons, and provides a novel approach for using gene therapies for disorders of axonal function.
INTRODUCTION
Axon injury is a feature of traumatic nerve injury as well as numerous peripheral neuropathies. In these conditions, axon regeneration, elongation and reinnervation of target tissue is needed to restore neuronal connectivity and function. However, axon regeneration is typically slow in the peripheral nervous system, and is highly inefficient in the central nervous system because of inhibitors of axonal growth at injury sites. 1, 2 A major therapeutic goal is to develop approaches to reactivate the developmental axonal growth and guidance programs in injured axons in order to re-establish functional neuronal circuitry. 2 Although gene therapy can be used to manipulate gene expression in a variety of cell types, it cannot readily be used to express growth-promoting genes specifically in injured axons. 3 Many gene therapy viruses require transcription steps in the cell body or nucleus. 4 Additionally, gene therapy directed toward neurons may lead to ubiquitous expression of transgenes throughout the cell, instead of selective expression in axons.
Proteins that influence axonal growth may have undesirable effects on neuronal morphology if they are not axonally restricted, which is a feature of several signaling proteins that have roles in axonal elongation during development. 5 A mechanism to selectively control the spatial expression of proteins in neurons is local translation. Local translation is particularly important during embryonic development, when elongating axons contain readily detectable ribosomes and mRNA. 6 Many mRNAs in embryonic axons encode for proteins that influence axonal growth and guidance. 6, 7 After the establishment of neuronal circuitry, ribosomes and mRNA are no longer readily detectable in axons. 8 For example, electron microscopy (EM) studies of axons from mature, myelinated neurons have not detected the classical rosette structures that reflect actively translating polyribosomes in the distal axon. 9 --12 Alternative approaches for imaging ribosomes, such as RNA-binding dyes and electron spectroscopic detection of phosphorus, which is abundant in ribosomes, support the presence of ribosomes in the axoplasm of myelinated neurons in adults, 13 but the potential nonspecificity of these techniques has prevented definitive conclusions regarding axonal localization of ribosomes. 6 Here, we describe the design of a virus that utilizes axonal ribosomes and local translation to reprogram axonal protein expression specifically in axons and promote axonal growth. Using a transgenic mouse that expresses enhanced green fluorescent protein (eGFP)-tagged ribosomes in cortical neurons, we show that ribosomes are present in adult central nervous system myelinated axons and are selectively enriched at the nodes of Ranvier. We describe the construction of a modified Sindbis virus that contains an RNA genome that can be used as a template for translation by axonal ribosomes, and show that this virus can be used to induce heterologous gene expression specifically in axons. We use this virus to induce axonal expression of soluble adenylyl cyclase (sAC), an enzyme that generates the axon-growth enhancing second messenger cyclic adenosine monophosphate (cAMP). Selective axonal expression of sAC increases axonal growth rates and overcomes the axon-growth inhibitory effects of components of the glial scar. We also show that application of this virus to axons in rat spinal cord leads to heterologous gene expression in axons in vivo, indicating that this modified Sindbis virus can be used to target and manipulate protein expression in axons in adult animals.
RESULTS
Ribosomes are localized to nodes of Ranvier in corticospinal tract axons Although EM studies have not provided convincing evidence of axonal ribosomes in the central nervous system of adult animals, 14 there are several reasons why axonal ribosomes may have been overlooked. For example, if axonal ribosomes do not aggregate into electron dense rosette structures or if they are obscured by other electron dense structures, they will not be readily detected. 9 Immunohistochemical techniques to detect ribosomes have been complicated by nonspecificity of the antibodies. 15 Experiments to demonstrate the specificity of antibody staining would require demonstrating the loss of immunoreactivity in knockout animals, which is not possible for genes that encode proteins required for cell viability, such as ribosome subunits.
To determine if ribosomes are present in axons of mature neurons, we used a genetic strategy to overcome the technical issues associated with labeling and identifying ribosomes in axons. We used mice expressing eGFP fused to the large ribosomal subunit protein, L10a. The eGFP --L10a fusion is stable, and is not associated with significant cleavage of the eGFP from the L10a. 16 The expression of this transgene is under the control of the Glt25d2 promoter, which drives expression in layer 5b cortical neurons. 17 These neurons include neurons of the motor cortex that project axons into the spinal cord and constitute the corticospinal tract. 18 As the corticospinal tract is the only portion of the spinal cord that derives from cortical neurons, any eGFP labeling in the spinal cord must derive from axons of cortical motor neurons, and not from any adjacent supporting cells. Additionally, as wild-type mice do not express eGFP, anti-eGFP immunostaining in these mice can be used to establish the specificity of labeling in axons.
We first confirmed that eGFP --L10a-labeled ribosomes are localized to rough endoplasmic reticulum and dendrites in a manner consistent with previous reports. 19 Immunoelectron microscopy using anti-eGFP antibodies revealed characteristic ribosome labeling in rough endoplasmic reticulum and dendrites in the cortex of adult Glt25d2HeGFP-L10a mice (Figure 1a) . These localizations are essentially identical to previously reported ribosome localizations based on their characteristic electrondense structure. 19 No specific signal was detected in the cell body or dendrites of neurons in wild-type mice (Figure 1b) .
We next examined whether ribosomes are present in axons of adult animals. We sectioned thoracic level (T) 7 --8 spinal cords and examined eGFP expression in the corticospinal tract of wild-type and Glt25d2HeGFP-L10a mice by anti-eGFP immunoelectron microscopy. In these mice, a striking enrichment of eGFP labeling was detected at nodes of Ranvier (Figure 1c ). Labeling primarily appeared as a cluster of immunoreactive signals just under the membrane at the node. Anti-eGFP labeling was detected in approximately 100% of nodes of Ranvier in the corticospinal tract of Glt25d2HeGFP-L10a mice, while labeling was not observed in any nodes in wild-type mice (Figure 1d ). This nodal localization of immunoreactivity was also confirmed using anti-GFP antibodies with an alternate method of visualization (Supplementary Figure 1) . Together, these data indicate that ribosomes are present in the corticospinal tract in adult animals and are selectively localized to nodes of Ranvier.
We next examined whether this labeling was altered after axonal injury. Adult mice were subjected to a dorsal hemisection injury at the level of T8 and then analyzed approximately 500 mm rostral to the injury site at 24-h and 7-day after injury. Anti-eGFP labeling remained detectable at the nodes, with no obvious change in signal localization, suggesting that injury of corticospinal tracts does not lead to increased translocation of ribosomes in the injured axon within this time period (Supplementary Figure 2) . As a result of their low frequency and small size, regenerating growth cones are technically challenging to locate in tissue. Nevertheless, we identified a regenerating growth cone based on its similarity in morphology and composition to previous EM descriptions, 20 emerging from an injured myelinated axon in the corticospinal tract of a Glt25d2H eGFP-L10a mouse 7-day after injury. This growth cone also exhibited eGFP-positive labeling, indicating that ribosomes are present within regenerating growth cones (Supplementary Figure 3) .
Design of a Sindbis genome that expresses transgenes in axons As axons of adult animals contain ribosomes, we asked whether these ribosomes could be used to translate heterologous RNA that is selectively introduced into axons, thereby influencing local protein expression to promote axonal regeneration. We considered the possibility of using an RNA virus to selectively introduce RNA into axons. Alphaviruses, such as Sindbis and Semliki forest virus, consist of a single-stranded, plus-strand RNA genome with a 5 0 cap and a 3 0 poly(A) tail. 21 The Sindbis virus genome encodes a coat protein, which renders the virus highly neuron specific, although the coat protein can be altered to affect viral tropism. 22, 23 On entry into the cell, virally encoded RNA-dependent RNA polymerase amplifies the genomic RNA, and generates transcripts that are under the control of a subgenomic promoter within the genomic RNA. As Sindbis is not retrogradely trafficked from axons, 21 and because axons may not contain sufficient ribonucleotide triphosphates substrates used by the nucleus-localized cellular RNA polymerases, axonal infection of Sindbis is unlikely to lead to productive infection.
Several studies have utilized internal ribosome entry site (IRES) sequences to drive transgene expression in Semliki forest and Sindbis viruses as an alternative to the subgenomic promoter. 24, 25 We considered that the IRES sequence could permit the Sindbis genome to be used as a direct template for translation by axonal ribosomes (Figure 2a ). We used a Sindbis virus containing the 586-nt human encephalomyocarditis virus IRES sequence based on its ability to promote internal initiation of RNA translation in a broad range of cell types, including neurons. 26 The IRES sequence was inserted into the Sindbis virus expression plasmid, SINrep(nsP2S 726 ), that contains a point mutation in the nonstructural protein nsP2, which minimizes neurotoxicity. (c) Application of Sindbis --IRES --eGFP to the axonal compartment does not result in detectable eGFP in cell bodies. Embryonic day 15 (E15) rat DRG neurons were cultured in microfluidic chambers and either Sindbis --IRES --eGFP or vehicle as indicated (above the line) was added to the indicated compartments (below the line). eGFP expression in cell bodies was detected by anti-eGFP immunofluorescence, and Tau expression was used to label neuronal cell bodies and processes after 8 h. Scale bar, 50 mm. (d) Axon-specific infection with Sindbis --IRES --eGFP leads to local translation of eGFP. Sindbis --IRES --eGFP was applied to the axonal compartment as indicated, and axonal expression of eGFP was detected by immunofluorescence. Axons were counterstained with Tau. Scale bar, 100 mm.
To determine if the Sindbis --IRES RNA genome can serve as a template for translation within axons, embryonic day 15 rat dorsal root ganglia (DRG) neurons were plated in compartmentalized microfluidic culture chambers. These chambers allow the fluidic isolation of axons from cell bodies by means of a volume differential of media between the two compartments. Microfluidic chambers provide an experimental system in which Sindbis virus can be selectively applied to either cell bodies or axons without diffusion to the other compartment 28 ( Figure 2b ). We applied Sindbis --IRES virus driving the expression of eGFP (Sindbis --IRES --eGFP) either to both the axonal and cell body compartments or to only the axonal compartment. As expected, application of Sindbis --IRES --eGFP to both compartments resulted in robust eGFP expression throughout the neuron and axon (Figure 2c ). However, application of Sindbis --IRES --eGFP selectively to the axonal compartment resulted in eGFP expression in essentially all axons with no detectable eGFP in cell bodies (Figure 2d ). The absence of eGFP expression in the cell bodies and proximal axons located within the cell body compartment indicates that the axonally localized eGFP was synthesized within axons, without the need for viral replication and eGFP transcription or translation in the cell body.
To further confirm that the eGFP detected in axons was synthesized locally, we preincubated the axonal compartment with the protein synthesis inhibitor cycloheximide for 30 min before axonal infection with Sindbis --IRES --eGFP. With cycloheximide in the axonal compartment, eGFP levels in axons were abolished, demonstrating that intra-axonal synthesis is necessary for protein expression elicited by axonal infection with Sindbis --IRES virus particles (Figure 2d ). Addition of cycloheximide to the cell body compartment 30 min before axonal infection did not alter eGFP expression in axons, demonstrating that axonal synthesis is sufficient for protein expression (Figure 2d) . The eGFP expression level observed in distal axons after application of the Sindbis --IRES particles specifically to the axonal compartment was B20% as intense as when the Sindbis --IRES virus was applied to both compartments reflects the increase in the efficiency of eGFP expression resulting from the amplification of the Sindbis viral genome in the cell body. 21, 29 Although eGFP could diffuse from axons to cell bodies, we did not detect significant increases in eGFP in the cell body after axon-specific expression of eGFP, possibly due to dilution of the protein as it diffused into the cell body.
Expression and functional activity of transgenes in axons We next sought to identify proteins that could be used to promote axonal regeneration when selectively expressed in axons. cAMP and cAMP-stimulating molecules have been shown to increase axonal growth both in vitro and when administered systemically to animals that have been subjected to models of spinal cord injury. 30, 31 However, cAMP-stimulating molecules affect many organ systems and systemic administration may have numerous nonspecific effects. 32 Selectively increasing cAMP in axons by genetic manipulation might provide an approach to bypass problems of systemic administration of cAMP. Unlike canonical transmembrane adenylyl cyclases, sAC is a cytosolic cAMPgenerating enzyme. As it is not inserted into membranes, it may be readily expressed in axons, which may have limited capacity to insert locally synthesized proteins into membranes. 33 We focused on a truncated form of sAC, sACt, which is considerably shorter than the longer isoforms expressed in neurons and has high constitutive basal activity. 34 We next asked if axonal expression of sACt mimics the effects of pharmacologic manipulation of cAMP in axons. One mechanism by which cAMP stimulates axonal growth across inhibitory substrates is by inducing transcription and translation of growth-promoting genes in the cell body. 30, 35 Indeed, pharmacological increases in axonal cAMP induce the phosphorylated form of cAMP response element-binding protein (pCREB) in the nucleus, which stimulates expression of genes required for axonal growth. 36 To determine if axonal sAC expression exhibits a similar effect, we infected axons with Sindbis --IRES virus driving the expression of eGFP --sACt (Sindbis --IRES --eGFP --sACt). Postnatal rat DRG neurons were cultured in microfluidic chambers, and axons were observed to cross into the axonal compartment by day in vitro two (DIV 2). Selective application of Sindbis --IRES --eGFP --sACt to axons on DIV 2 led to the expression of eGFP --sACt in axons by DIV 3, with little to no expression detected in the cell body (Figure 3a) . To determine if axonally expressed sACt mimicked the effects of pharmacologic manipulation of cAMP, we monitored levels of pCREB after selective application of Sindbis --IRES --eGFP --sACt. Nuclear pCREB levels were identical in neurons whose axons were treated with vehicle or infected with the control virus, Sindbis --IRES --eGFP. However, infection of axons with Sindbis --IRES --eGFP --sACt increased the levels of pCREB to a level similar to that induced by axonal application of 10 mM 8-Br-cAMP, a cell-permeable, non-hydrolysable cAMP analog (Figure 3b ). The effect of axonal application of Sindbis --IRES --eGFP --sACt was blocked by pretreatment with cycloheximide in the axonal compartment, confirming that the effect of Sindbis --IRES --eGFP --sACt was mediated by axonal synthesis of eGFP --sACt (Figure 3c ). The ability of axonal eGFP --sACt expression to induce an increase in nuclear pCREB levels indicates that transgene expression encoded by the Sindbis --IRES virus is sufficient to induce retrograde signaling to the nucleus.
Axonal expression of eGFP --sACt promotes axonal growth on inhibitory substrates Axon regeneration after injury is limited because of inhibitory substances found in myelin and the glial scar. 37 A component of the glial scar, chondroitin sulfate proteoglycan (CSPG), 38 acts on receptors on distal axons to inhibit axonal growth. 39, 40 In most studies, the inhibitory effects of CSPG on axon growth are detected by plating neurons directly on a substratum containing CSPG. However, this approach results in CSPG exposure to both the cell body and axons, which differs from the selective axonal exposure to CSPG that occurs after injury. To study pathways affecting CSPG signaling in axons, we developed a microfluidic culture system to model the selective exposure of elongating axons to CSPG. In this system, CSPG is present only in the axonal compartment, so that only the distal axons are exposed to CSPG, similar to the selective exposure of CSPG to axon terminals in nerve injuries. We next addressed whether axons that encounter CSPG exhibit reduced elongation rates. To test this, we used postnatal DRG neurons, because these neurons exhibit reduced axonal growth in response to CSPG. 41 Axons growing into the axonal compartments containing CSPG in the substratum exhibited an approximately 50% reduction in axon growth rate compared with axons growing into axonal chambers containing laminin alone (Figure 4a ). The reduced growth rate indicates that selective exposure of axons to CSPG induces an inhibitory effect on axonal growth rates.
We next sought to use the Sindbis --IRES system to overcome the growth inhibition of CSPG. Axon growth inhibitory signaling from the components of the glial scar, such as CSPG, has been found to be attenuated by cAMP-regulated signaling pathways. 30 Thus, we next examined the growth properties of axons expressing eGFP --sACt across CSPG containing substratum. Compared with axons expressing eGFP, axons expressing eGFP --sACt exhibited growth rates comparable to axons treated with 10 mM 8-Br-cAMP, and to control axons grown on CSPG-free substratum (Figure 4b ). These data indicate that axon-specific expression of eGFP-sACt allows axons to overcome the inhibitory effects of CSPG. Together, these data indicate that axonal eGFP --sACt expression can activate CREB signaling and increase axonal growth on CSPG, suggesting that the Sindbis --IRES approach can be used to identify candidate proteins that might be suitable for promoting axon regeneration.
Targeting eGFP --sACt to spinal cord axons We next asked whether Sindbis --IRES virus can be used to target axons in the corticospinal tract. Cortical injections of the Sindbis virus from which the Sindbis --IRES virus was derived results in marked neuronal-specific infection, and transgene expression for up to 4 weeks, 22 suggesting that Sindbis --IRES virus may be useful for manipulating protein expression in axons in vivo. To test the ability of the Sindbis --IRES virus to selectively infect axons in vivo, we stereotaxically injected Sindbis --IRES --eGFP --sACt into the spinal cord of adult mice. After 4 days, animals were killed and the corticospinal tract was immunostained with anti-eGFP antibodies. Immunolabeling revealed eGFP-positive axons colocalized with Tuj1, an axonal marker. These axons were surrounded by, but not colocalized with, galactosylceramidase labeling, a marker for myelinating oligodendrocytes characteristic of corticospinal tract axons (Figure 4c, Supplementary Figure 4) . These data indicate that the Sindbis --IRES virus can be used to infect axons in vivo.
DISCUSSION
Here, we describe a viral strategy for targeting protein expression to the axonal compartment, rather than targeting protein expression throughout the neuron. This strategy relies on selective axonal application of an RNA virus that contains a genome designed to be a template for axonal ribosomes. Previous studies have described the mechanism of local translation in postnatal tissue, and this is the first study to utilize local translation to modify the protein content, and thus behavior, of axons both in vitro and in vivo. Selective expression of sACt in axons markedly affects axonal behavior, resulting in retrograde signaling and axonal growth over inhibitory substrates, in a manner similar to pharmacologic application of cell-permeable, non-hydrolysable cAMP analogs. We also describe a platform for testing whether candidate proteins can influence axonal behavior when selectively expressed in axons. Thus, these experiments provide a strategy for identifying proteins, such as sACt, which may be suitable for future in vivo studies of axon regeneration. Axon regeneration is a common therapeutic goal in the treatment a variety of disease states such as spinal cord injury and peripheral neuropathy. Our studies demonstrate a novel form of axon-specific gene therapy that can be used to influence axonal protein expression and promote axonal growth in these and other therapeutic contexts.
An important feature of the Sindbis --IRES system is the rapidity in which protein expression is induced. Direct translation of proteins from the IRES incorporated in the Sindbis genome can permit rapid changes in protein expression. Indeed, we see Sindbis --IRES-mediated protein expression in axons of cultured neurons at 8 h, the earliest time point tested. This is considerably faster than lentiviral and adenoviral-mediated transgene expression, which require viral genome amplification, and may also require time for protein transport into axons. 4 Thus, the Sindbis --IRES system may be particularly well suited for applications requiring rapid manipulation of protein expression after injury.
Selective expression of proteins in axons relies on the existence of axonal ribosomes. However, ribosome localization to axons and local translation is largely thought to be a phenomenon limited to growing embryonic axons. 8 Demonstration of ribosome localization in axons after the embryonic period has been limited to sensory axons of the peripheral nervous system. 13 However, these studies found that the electron dense structures consistent with ribosome clusters were in the portion of the axons near the cell body. For example, ribosomes were only found adjacent to the first node of Ranvier, 9 which may reflect diffusion of ribosomes from the cell body. Additionally, these studies did not detect ribosomes within the node, but in the adjacent paranode area of the first node of Ranvier. 9 The previous inability to detect ribosomes in more distal portions of the axon may have been due to the difficulty in detecting unclustered ribosomes without a specific antibody. Alternatively, the difference between our study and previous studies may reflect fundamental differences between axons in the peripheral and central nervous system. Our data provide the first electron microscopic demonstration of ribosomes in distal axons of an adult animal. Additionally, our finding of Sindbis --IRES-mediated eGFP --sACt expression in axons in the corticospinal tract of adult animals indicates that these ribosomes are functional and can translate heterologous RNA.
The localization of ribosomes to nodes of Ranvier may be particularly important to allow for local translation. Nodes are sites of nutrient transport 42 that may be important for providing amino acid precursors for local translation. Additionally, mitochondria can be recruited to nodes of Ranvier in electrically active axons. 43 As mitochondria provide amino acid precursors and ATP required for translation, ribosome localization at nodes of Ranvier may be required for efficient local translation. Alternatively, a major function of local translation is to synthesize proteins required for mitochondrial function. 44 The colocalization of ribosomes and mitochondria may be important for maintaining mitochondrial function in axons. Our finding that axons of adult animals contain ribosomes suggests that axons have a greater capacity for protein translation than was previously appreciated. Identification of mRNAs that associate with axonal ribosomes may provide insights into the function of intra-axonal translation in adult animals.
Notably, our data demonstrate that ribosomes are present in axons, even in the absence of injury. Axonal injury has been linked to the transfer of ribosomes from neighboring myelinating Schwann cells to axons in the peripheral nervous system. 45 The ribosomes we detect in axons are unlikely to have been transferred from neighboring cells because these cells do not express the eGFP --L10a construct, which is controlled by the cortical neuron-specific Glt25d2 promoter. However, ribosomes transferred from neighboring cells into axons would also contribute to the local translation capacity of axons, which may also be utilized by Sindbis --IRES constructs.
Our data also show an approach for identifying proteins that can function in axons to promote axon regeneration after injury. Using a novel microfluidic system to model spinal cord injury, we identified sACt as a protein that can induce increased pCREB levels and promote axonal growth across inhibitory substrates. Sindbis --IRES viruses utilized in the context of the microfluidic system can be used to test other axonally expressed proteins for their growth-promoting effects. Although we used a neurotropic Sindbis coat protein to target expression in axons, Sindbis infection could potentially be limited to specific neuronal types by modifying Sindbis coat proteins. We envision that the approach described here will provide an approach for gene therapy directed toward axons in axonal injury and peripheral neuropathy, enabling axons to be reprogrammed to promote axon growth and regeneration.
MATERIALS AND METHODS

Immunoelectron microscopy
Three 8-to 10-week-old C57bl/6 or Glt25d2HeGFP-L10a mice were compared in the uninjured group. Three Glt25d2HeGFP-L10a mice were subjected to dorsal hemisection and cared for postoperatively for 24 h or 7 days. Mice were deeply anesthetized with sodium pentobarbital (150 mg kg --1 , intraperitoneally) and perfused through the ascending aorta with 5 ml of heparin-saline, followed by 30 ml of 3.75% acrolein (Polysciences, Warrington, PA, USA) and 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The spinal cord was removed and post-fixed in the fixative for 30 min. Transverse sections, 40 mm thick, were cut through the cervical and thoracic spinal cords with a Leica vibratome (Lecia Microsystems, Bannockburn, IL, USA). Sections were processed for EM immunocytochemistry as described previously. 46 Briefly, sections were incubated in 1% sodium borohydride in phosphate buffer, rinsed, freeze --thawed and incubated in 0.5% bovine serum albumin in 0.1 M Tris-Saline (pH 7.6). Sections were incubated in a chicken anti-GFP mAb (Abcam, Cambridge, MA, USA) diluted 1:7500 in 0.1% bovine serum albumin for 48 h at 4 1C. Signal was visualized by incubating with species antichicken immunoglobulin G conjugated to biotin followed by incubation in avidtin --biotin complex then H 2 O 2 and diaminobenzidine. To confirm Quantification of axonal outgrowth rate in (a). Axon growth was normalized to the rate of vehicle-treated axons grown on laminin. Axons grow significantly slower across laminin containing CSPG than laminin alone (*Po0.0001, n ¼ 34 axons measured across a minimum of three experiments). Treatment of axons with 10 mM 8-Br-cAMP significantly increased outgrowth rates across CSPG as compared with vehicle control (*Po0.0001, n ¼ 41 axons measured across a minimum of three experiments). Axonal expression of eGFP --sACt significantly increased outgrowth rates across CSPG compared with axonal expression of eGFP, which itself was not significantly different than vehicle treatment on CSPG (*P ¼ 0.0002, n ¼ 29 axons measured across three experiments and P ¼ 0.657, n ¼ 28 axons measured across three experiments, respectively). Comparisons were made using the unpaired, two-tailed Student's t-test. Data are expressed as mean ± s.e.m. (c) In vivo expression of eGFP --sACt in axons in the corticospinal tract. eGFP --sACt levels in axons were detected by anti-eGFP immunofluorescence (green) and colocalized with Tuj1 staining (red) but not with galactosylceramidase (GalC) (red). Scale bar, 5 mm.
peroxidase labeling, a subset of sections were incubated a goat antichicken secondary antibody conjugated with 1 nm gold particles (Electron Microscopy Sciences, Hatfield, PA, USA). The conjugated gold particles were intensified with IntenSE silver solution (Amersham Biosciences, Piscataway, NJ, USA) for 5 min.
Sections for EM were embedded in Embed 812 (Electron Microscopy Sciences), and ultrathin sections (70 --72 nm) were prepared from the region of interest on a Leica UCT ultratome. Sections were counterstained with uranyl acetate and Reynold's lead citrate. All nodes within an approximately 1650 mm 2 area of corticospinal tract for each animal were imaged with an Advanced Microscopy Techniques camera on a Philips CM10 electron microscope (Philips Electronics, Eindhoven, The Netherlands), and captured images were analyzed using NIS-Elements software (Nikon, Tokyo, Japan). Nodes were deemed positive if a 67 nm 2 area below the nodal membrane was at least 2 s.d. more intensely labeled the wild-type average.
Cell culture and infection
All reagents were obtained from Invitrogen (Carlsbad, CA, USA), unless otherwise indicated. Coverslips (Assistant brand, Carolina Biological Supply, Burlington, NC, USA) were treated with a hand-held corona discharger (BD20-AC, Electro-Technic Products, Chicago, IL, USA) and precoated with 0.01% poly-L-lysine (Trevigen, Gaithersburg, MD, USA) overnight in a 371C incubator. The coverslips were rinsed with water, dried, and the microfluidic chambers were attached. The cell body side of the chamber was coated with 0.3 mg ml --1 laminin (Trevigen) and the axonal side was coated either with 0.3 mg ml --1 laminin alone or 0.3 mg ml --1 laminin mixed with 750 ng ml --1 CSPG (Millipore, Temecula, CA, USA) overnight at 37 1C.
Embryonic day 15 DRG neurons were obtained as described previously. 47 Postnatal DRG neurons were harvested from neonates on postnatal day 4 --6 and dissociated as described. 48 In brief, thoracic DRG ganglia were dissected from the spinal cord and treated twice at 37 1C with 1 ml of 0.1% collagenase (Worthington Biochemical, Freehold, NJ, USA) for 20 min followed by 1 ml TrypLE to detach satellite cells. Ganglia were allowed to settle by gravity, and the TrypLE was removed. Ganglia were mechanically dissociated with a flame-polished pasture pipette in 1 ml growth medium. Myelin debris were removed by passing the cell suspension through a 100 mm cell strainer (BD Biosciences, San Jose, CA, USA), and the suspended cells were layered onto a 32%/54% Percoll gradient and centrifuged for 8 min at 0.4 Â g to remove glial cells. 49 The enriched neuron population was collected from the interface and loosely pelleted in Hank's Balanced Salt Solution. Viable neurons were counted using Trypan blue, and approximately 50 000 neurons were plated on the cell body side of each microfluidic chamber.
On DIV 2, approximately 200 000 particles of Sindbis --IRES --eGFP --sACt or Sindbis --IRES --eGFP were selectively applied to axons and incubated for 8 to 12 h.
Virus cloning
The IRES-containing viral plasmid SINrep(nsP2S 726 ) was derived from the Sindbis virus expression system vector, pSinRep5, and contains a point mutation in the non-structural protein 2 (P726S) reducing its neurotoxicity. 22 The IRES element from the human encephalomyocarditis virus was amplified by PCR from pIRES-hyg (Clontech, Palo Alto, CA, USA) and inserted into pSinRep5 via XbaI and MluI restriction sites.
Myc --eGFP and myc --eGFP --sACt were assembled using the eGFP coding sequence from pEGFP (Clontech). A plasmid containing the sequence for rat sACt was a generous gift of Dr Levin and Dr Buck (Weill Cornell Medical College, NY, USA). The myc tag was incorporated into the PCR primer. Myc --eGFP --sACt constructs and myc --eGFP constructs were then inserted into pSinRep --IRES at the MluI and SphI restriction sites.
Virus expression
The Sindbis plasmid and virus particles were generated according to the instructions provided by Invitrogen, which previously sold the Sindbis viral system. The Sindbis plasmids and the helper plasmid TE12 were a generous gift of S Schlesinger and A Jeromin. 50 Briefly, both the Sindbis --IRES plasmid and helper plasmid were electroporated into BHK-21 cells and cultured for 48 h. Virus particle-containing cell supernatant was purified over a three-step sucrose gradient and concentrated on Centricon YM-100 centrifugal filter devices (Millipore). Particles were resuspended in phosphate-buffered saline (PBS), and PBS was used as the vehicle in control experiments. After freezing aliquots at --801C, the titer of viral stocks was determined by infecting a monolayer of BHK-21 cells with serial stock dilutions.
Immunocytochemistry
Neurons were fixed with 4% paraformaldehyde in PBS for 15 min at 25 1C, permeabilized in PBS/0.1%. Triton X-100 for 10 min, and blocked with blocking reagent for 30 min. Immunofluorescence was performed using the Tyramide Signal Amplification system (Perkin Elmer Corp., Norwalk, CT, USA), using anti-eGFP 1:2000 (Abcam) and anti-Tau 1:500 (Millipore). Secondary antibodies were anti-chicken horseradish peroxidase 1:1000 (Santa Cruz Technology, Beverly, CA, USA) and anti-mouse Alexa Fluor 568 (Invitrogen). Images were captured in NIS-Elements with a Nikon TE2000 microscope with a 40 Â objective and a CoolSNAP HQ 2 camera (Roper Scientific, Duluth, GA, USA). Only linear adjustments were made to the original images. pCREB assay Postnatal neurons were grown for 72 h in microfluidic chambers with a microgroove length of 450 mm. In all, 100 ml of medium was removed from the axonal compartment to ensure fluidic isolation. Axons were preincubated for 30 min with either 1 mM cycloheximide or vehicle before approximately 750 000 infectious Sindbis virus particles or vehicle was added to the axonal compartment. Cells were incubated for 8 h. At 2 h before fixation, crossed neurons were labeled with Vybrant DiI (Invitrogen). At 1 h before fixation, either 10 mM 8-Br-cAMP (Sigma Aldrich, St Louis, MO, USA) or vehicle were added to the axonal compartment. Neurons were fixed with 4% paraformaldehyde in PBS for 15 min at 25 1C, permeabilized in PBS/0.1% Triton X-100 for 10 min and blocked with 10% normal goat serum for 30 min. pCREB was visualized with anti-pCREB (Ser133) clone 87G3 at 1:500 (Cell Signaling Technology, Beverly, CA, USA) and anti-rabbit Alexa Fluor 647 (Invitrogen) antibodies. The background level of pCREB was set according to the average nuclear intensity of the vehicle control slide, and nuclei 42 s.d. above the average in DiI-positive cells were considered positive.
Outgrowth assay
Neurons were grown in microfluidic chambers with microgroove length of 450 mm. After 48 h, 100 ml of fresh medium was added to the cell body compartment to ensure microfluidic isolation from the axonal compartment, and approximately 750 000 infectious Sindbis virus particles or vehicle were added to the axonal compartment. Axons were incubated for an additional 24 --30 h. At 30 min before imaging, 10 mM of 8-Br-cAMP (Sigma Aldrich) or vehicle was added to the axonal compartment. Phase contrast images of the axonal compartment were captured at time point zero, and again 3 h later, on a Nikon TE2000 microscope with a 20 Â objective and a CoolSNAP HQ 2 camera. Differences in axon length were measured using NIS-Elements software (Nikon) by an investigator blinded to treatment condition. Experimental groups were uncoded only after imaging and data analysis.
Intraparenchymal injection of virus
All procedures and animal care were approved by the Weill Cornell Medical College Institutional Animal Care and Use Committee and were in accordance with the National Institutes of Health guidelines. Male, wild-type, c57bl/6 mice between 8 and 10 weeks old were anesthetized with isoflourane and placed in a stereotaxic unit (model 960; David Kopf Instruments, Tujunga, CA, USA). Vertebrae T7 and T8 were removed by laminectomy. One injection of 1 ml of virus (B15 000 particles per ml) was administered with a Hamilton syringe mounted on a microinjector (model 5000; David Kopf Instruments at the level of T7 and a depth of 0.5 mm below the dura. Virus was injected over the span of 3 min, and the needle was held in place for an additional 5 min to increase viral spread. After removal of the needle, the spinal cord was completely transected with a scalpel at the level of T8.
Immunofluorescence of spinal cords
Mice were deeply anesthetized with sodium pentobarbital (150 mg kg --1 , intraperitoneally) and transcardially perfused with 5 ml heparin-saline followed by 20 ml of 4% paraformaldehyde in PBS. The spinal cord was placed in 4% paraformaldehyde for 1 h before being cryoprotected in 30% sucrose for 72 h. The spinal cord was cut into four 5 mm sections frozen together in a mold with Optimal Cutting Temperature compound. The cords were cut longitudinally on a cryostat in 14 mm thick sections and collected on Superfrost Plus slides. Sections were blocked with 10% bovine serum albumin/0.25% Tween 20 for 30 min before incubating with primary antibody in a humidified chamber overnight at 4 1C.
Immunofluorescence was performed using anti-GFP 1:1000 (Abcam), anti-galactosylceramidase 1:500 (Millipore), and anti-Tuj1 1:500 (Covance Laboratories, Berkeley, CA, USA). Secondary antibodies were anti-rabbit Alexa Fluor 488, anti-chicken Alexa Fluor 568 and anti-mouse Alexa Fluor 647. Images were captured in NIS-Elements with a Nikon TE2000 microscope with a 40 Â objective and a CoolSNAP HQ 2 camera. Only linear adjustments were made to the original images.
Statistical analysis
As the data are normal and without significant variances, statistical analysis was performed using two-tailed, unpaired Student's t-tests and one-way analysis of variance with Bonferroni post tests. GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA) was used for statistical analysis. All alpha levels were set to be 5%.
